← Back to headlines
Alnylam Pharmaceuticals and Inceptive Form $2B Partnership for RNAi Drug Discovery
Alnylam Pharmaceuticals (ALNY) and Inceptive have formed a $2 billion partnership aimed at advancing RNAi drug discovery, combining their expertise to develop new therapeutic solutions.
23 Jun, 19:18 — 23 Jun, 19:18
Sources
Showing 1 of 1 sources
